U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C31H31N5O2S2.ClH.H2O
Molecular Weight 624.216
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SRT-3025 HYDROCHLORIDE MONOHYDRATE

SMILES

O.Cl.COCCCC1=C(N=C(S1)C2=CC=CC=C2)C(=O)NC3=CC=CC=C3C4=NC5=C(S4)N=CC(CN6CCCC6)=C5

InChI

InChIKey=FJVWKTGCZLWDEP-UHFFFAOYSA-N
InChI=1S/C31H31N5O2S2.ClH.H2O/c1-38-17-9-14-26-27(35-29(39-26)22-10-3-2-4-11-22)28(37)33-24-13-6-5-12-23(24)30-34-25-18-21(19-32-31(25)40-30)20-36-15-7-8-16-36;;/h2-6,10-13,18-19H,7-9,14-17,20H2,1H3,(H,33,37);1H;1H2

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C31H31N5O2S2
Molecular Weight 569.74
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

SIRTUIN MODULATOR 1 is a sirtuin modulator developed by Sirtris Pharmaceuticals, Inc. for treating insulin resistance and metabolic syndrome.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
The mass spectrometry assay is conducted as follows: 0.5 μM peptide substrate and 120 μM βNAD+ is incubated with 10 nM SIRTl for 25 minutes at 250C in a reaction buffer (50 mM Tris-acetate pH 8, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 5 mM DTT, 0.05% BSA). SIRTUIN MODULATOR 1 was added to the reaction and after the 25 minute incubation with SIRTl, 10 μL of 10% formic acid is added to stop the reaction. Reactions are sealed and frozen for later mass spec analysis
Substance Class Chemical
Created
by admin
on Wed Apr 02 20:31:57 GMT 2025
Edited
by admin
on Wed Apr 02 20:31:57 GMT 2025
Record UNII
3UUH4AN9EW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SRT-3025 HYDROCHLORIDE MONOHYDRATE
Common Name English
SRT3025 HYDROCHLORIDE MONOHYDRATE
Preferred Name English
4-THIAZOLECARBOXAMIDE, 5-(3-METHOXYPROPYL)-2-PHENYL-N-(2-(6-(1-PYRROLIDINYLMETHYL)THIAZOLO(5,4-B)PYRIDIN-2-YL)PHENYL)-, HYDROCHLORIDE HYDRATE (1:1:1)
Systematic Name English
Code System Code Type Description
FDA UNII
3UUH4AN9EW
Created by admin on Wed Apr 02 20:31:57 GMT 2025 , Edited by admin on Wed Apr 02 20:31:57 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ANHYDROUS->SOLVATE
Related Record Type Details
ACTIVE MOIETY